BlueScope Steel Forecasts Stronger Second-Half Earnings, Shares Rise Above Rejected Buyout Offer 
Yotta to Build $2 Billion AI Data Centre Hub in India with Nvidia Blackwell Ultra Chips 
Freedom Finance and Binance Join Forces in Digital Assets 
Goldman Sachs Reportedly Drops Diversity Criteria From Board Candidate Evaluations 
Microsoft Plans $50 Billion AI Investment to Accelerate Growth in the Global South 
Medical Groups Sue FTC Over Gender-Affirming Care Investigations Amid Trump Policy Dispute 
AstroTurf Expands Footprint at Colorado as Buffaloes Complete Second Installation in 12 Months 
Stock Market Movers: NVIDIA and Meta Expand AI Partnership as Cadence Surges on Earnings 
NAB Shares Hit Record High as First-Quarter Cash Earnings Jump 16% 
Thomas Pritzker to Step Down as Hyatt Executive Chairman After Epstein Ties Acknowledged 
India AI Impact Summit 2026: Global Tech CEOs Join World Leaders in New Delhi 
Starboard Value Targets Tripadvisor Board Overhaul Amid Stock Slump 
Ireland’s Data Protection Commission Launches GDPR Investigation Into X’s AI Chatbot Grok 
BHP Group Half-Year Profit Surges as Copper Overtakes Iron Ore on AI-Driven Demand 
Disney Issues Cease-and-Desist to ByteDance Over Alleged AI Copyright Infringement 
Treasury Wine Estates Profit Falls 46% as China and U.S. Inventory Reset Weighs on Earnings 
Mitsui Kinzoku Stock Surges to Record High After Profit Forecast Upgrade and Dividend Increase 
NEW YORK, May 01, 2018 -- NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that it will be presenting at the 3rd annual Disruptive Growth & Healthcare Conference in New York City on Tuesday, May 8th at 1:45 PM, Eastern Time. Chief Executive Officer of NanoVibronix, Brian Murphy, will be presenting, as well as meeting with investors. Mr. Murphy will also be presenting on the Disruptive Pain Management Panel at 3:00 PM on May 8th.
The 2018 Disruptive Growth & Healthcare Conference will offer investors the opportunity to discover life science companies focusing on solutions for unmet medical needs and growth companies with disruptive technologies and business models.
About NanoVibronix
NanoVibronix Inc. (NASDAQ:NAOV) is a medical device company headquartered in Elmsford, NY with research and development in Nesher, Israel, that is focused on developing medical devices utilizing its proprietary and patented low intensity surface acoustic wave technology. The company's technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including the disruption of biofilms and bacteria colonization, as well as providing pain relief. The devices can be administered at home, without the assistance of medical professionals. The company's primary products include PainShield®, UroShield™ and WoundShield™. Additional information about the company is available at: www.nanovibronix.com.
About RHK Capital:
Advisory Group Equity Services, Ltd. (dba RHK Capital) was founded in 1984. RHK Capital is a boutique investment banking firm specializing in small to medium-sized transactions. RHK is led by a management team with extensive financial industry experience and a desire to provide companies and individuals with the tools and expertise to accomplish their financial goals. In addition to investment banking, RHK has grown to include businesses in general securities, emerging market securities, distressed and high yield debt securities, investment management, mortgages, and business lending. As a division of Advisory Group Equity Services (AGES), all securities are offered through Advisory Group Equity Services Ltd., a registered broker-dealer, member of the Financial Industry Regulatory Authority and the Securities Investor Protection Corporation.
Investor Contacts:
Crescendo Communications
[email protected]
(212) 671-1021
